AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0149
0.00 (0.00%)
Jul 26, 2024, 1:57 PM EDT - Market closed
AXIM Biotechnologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.09 | 0.04 | 0.01 | 0.06 | - | - | Upgrade
|
| Revenue Growth (YoY) | 422.98% | 345.27% | -85.32% | - | - | - | Upgrade
|
| Gross Profit | 0.09 | 0.04 | 0.01 | 0.06 | - | - | Upgrade
|
| Selling, General & Admin | 1.98 | 2.24 | 4.08 | 5.67 | 4.51 | 3.11 | Upgrade
|
| Research & Development | 0.12 | 0.13 | 0.15 | 0.28 | 0.43 | - | Upgrade
|
| Depreciation & Amortization | 0.43 | 0.43 | 0.43 | 2.12 | 0.02 | 0 | Upgrade
|
| Operating Expenses | 2.53 | 2.79 | 4.66 | 8.07 | 4.95 | 3.11 | Upgrade
|
| Operating Income | -2.44 | -2.75 | -4.65 | -8.01 | -4.95 | -3.11 | Upgrade
|
| Interest Expense | -1.34 | -1.2 | -1.88 | -0.49 | -0.32 | -0.3 | Upgrade
|
| Interest & Investment Income | - | - | 0 | 0 | 0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.85 | -3.31 | 0.77 | 0.02 | 0.12 | 0.06 | Upgrade
|
| EBT Excluding Unusual Items | -4.63 | -7.27 | -5.76 | -8.47 | -5.15 | -3.35 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.21 | 0.38 | Upgrade
|
| Asset Writedown | - | - | - | -5.97 | - | - | Upgrade
|
| Legal Settlements | -0.96 | -0.96 | - | - | - | - | Upgrade
|
| Other Unusual Items | -0 | 0.16 | -0.48 | -1.59 | -0.92 | - | Upgrade
|
| Pretax Income | -5.59 | -8.06 | -6.24 | -16.02 | -6.29 | -2.97 | Upgrade
|
| Earnings From Continuing Operations | -5.59 | -8.06 | -6.24 | -16.02 | -6.29 | -2.97 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -0.01 | -0.12 | -3.48 | Upgrade
|
| Net Income | -5.59 | -8.06 | -6.24 | -16.03 | -6.41 | -6.45 | Upgrade
|
| Net Income to Common | -5.59 | -8.06 | -6.24 | -16.03 | -6.41 | -6.45 | Upgrade
|
| Shares Outstanding (Basic) | 239 | 228 | 165 | 132 | 110 | 62 | Upgrade
|
| Shares Outstanding (Diluted) | 239 | 228 | 165 | 132 | 110 | 62 | Upgrade
|
| Shares Change (YoY) | 31.33% | 37.60% | 25.79% | 19.16% | 78.19% | 8.14% | Upgrade
|
| EPS (Basic) | -0.02 | -0.04 | -0.04 | -0.12 | -0.06 | -0.10 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.04 | -0.04 | -0.12 | -0.06 | -0.11 | Upgrade
|
| Free Cash Flow | -1.96 | -1.03 | -2.05 | -2.53 | -3.31 | -5.04 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.01 | -0.02 | -0.03 | -0.08 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | - | - | Upgrade
|
| Operating Margin | -2872.58% | -6960.98% | -52425.60% | -13246.02% | - | - | Upgrade
|
| Free Cash Flow Margin | -2301.34% | -2607.67% | -23132.80% | -4180.05% | - | - | Upgrade
|
| EBITDA | -2.02 | -2.32 | -4.23 | -5.89 | -4.93 | -3.11 | Upgrade
|
| D&A For EBITDA | 0.43 | 0.43 | 0.43 | 2.12 | 0.02 | 0 | Upgrade
|
| EBIT | -2.44 | -2.75 | -4.65 | -8.01 | -4.95 | -3.11 | Upgrade
|
Source: S&P Capital IQ. Standard template.